Feline intestinal lymphoma, cognitive dysfunction to be exploredDecember 22, 2022Tooth resorption, cognitive dysfunction syndrome, and oral squamous cell carcinoma are among the topics of six newly funded feline-focused studies.
SPONSORED CONTENTProtect your patients from the start.Simparica Trio (sarolaner, moxidectin, and pyrantel chewable tablets) is the first monthly preventative of its kind. Combining three ingredients for month-long protection. + Learn more
Nonsurgical feline sterilization methods to be exploredNovember 22, 2022Controlling the skyrocketing population of free-roaming cats in the United States and improving overall feline health are the dual goals of two recently launched studies. Morris Animal Foundation has announced funding for research projects at the University of Georgia and Tufts University, both of which will focus on developing methods for nonsurgical cat sterilization to control reproductive capacity. Researchers at the University of Georgia will work to develop an oral vaccine to decrease male cat fertility by reducing reproductive hormone levels, while scientists at Tufts will focus on decreasing hormone levels in female cats through an injectable medication. Currently, there are an estimated 60 million to 100 million free-roaming, community cats in the U.S., Morris Animal Foundation reports. The newly funded projects hope to develop strategies for controlling this population beyond trap/neuter/release programs, effectively reducing the number of cats entering animal shelters. "The importance of finding viable, safe, humane, and cost-effective techniques for nonsurgical sterilization in community cats cannot be overstated," says Morris Animal Foundation's vice president of scientific operations, Kathy Tietje, PhD, MBA. "We're excited about these innovative projects and their impact on population control of this specific group …
Feline respiratory health "static" amid pandemicApril 14, 2020North America’s domestic cats appear to be maintaining good respiratory health amid the COVID-19 pandemic.
Feline-friendly tactics help boost the bottom lineMarch 12, 2020Refining the cat-handling skills of team members can help get feline patients through the door and on an exam table.
Smoke inhalation, burns may lead to heart problems in catsFebruary 27, 2020Suffering moderate burns and smoke inhalation might have a detrimental effect on the cardiovascular health of animals, according to a new study out of the University of California, Davis, Veterinary Medical Teaching Hospital (UC Davis VMTH).
Study to use DNA to decode feline diabetesNovember 13, 2019Participants are being sought for a new study that aims to expand the understanding of feline diabetes and help advance cat health.
Cat virus could be linked to feline cancerOctober 25, 2019Australian researchers believe a newly discovered feline virus might be the cause of liver cancer in cats, and that this link could lead to the development of new anti-cancer therapies.
KSU veterinary researchers, Anivive license FIP antiviral drugSeptember 20, 2018A collaboration at Kansas State University and Anivive Lifesciences is promoting the commercial development of GC376, an antiviral compound for feline infectious peritonitis (FIP), which previously has had no effective treatment or cure. Yunjeong Kim, DVM, PhD, ACVM, and Kyeong-Ok "KC" Chang, DVM, MS, PhD, virologists at KSU's College of Veterinary Medicine, and William Groutas, a medicinal chemist at Wichita State University, have been collaborating since 2006 to develop antiviral drugs for human and animal viruses. The licensing agreement was coordinated by the KSU Institute for Commercialization with Anivive Lifesciences, a California company whose proprietary software accelerates the discovery and development process of new pet medicines. "We have been working on antiviral drugs that inhibit a specific virus protease of some important human and animal viruses, and we were able to make very potent inhibitors of FIP," Dr. Kim said. "Through collaborative work with Niels Pedersen at the University of California, Davis—including a field trial on feline patients—we became increasingly hopeful that antiviral treatment may one day substantially benefit cats with FIP. Licensing our compound to Anivive Lifesciences is a huge step forward in transitioning our research to commercialization to make this treatment available to the …
Veterinary Emerging Topics Report for 2018 focuses on AMRFebruary 15, 2018Banfield Pet Hospital and the North American Veterinary Community (NAVC) have published the second annual Veterinary Emerging Topics (VET) Report. This year's report focuses on feline antimicrobial usage and the mounting public health issue of antimicrobial resistance (AMR), expanding the 2017 conversation that discussed canine patients. "Our second annual VET Report enables Banfield to continue its commitment to advancing pet health," said Daniel Aja, DVM, chief medical officer, Banfield Pet Hospital. " … Our … goal is to give veterinarians around the world information they need to provide the best care possible to feline patients, while also educating pet owners and the general public on the issue of AMR in companion animals." A lack of awareness around existing guidelines for antimicrobial usage in veterinary medicine has contributed to discordance between usage patterns and ideal treatments, according to the report. The 2018 publication highlights these guidelines and places a special focus on prescription patterns in common feline infections, considering the unique challenges cat owners face treating their feline companions, such as hiding behavior and defense mechanisms, the report stated. Research examined the treatment of upper respiratory infections and urinary tract infections in feline patients. Key findings include: 40 percent of …
